Combination of PARP inhibition plus chemotherapy in ovarian cancer Presented ByRobert Coleman, University of Texas, MD Anderson Cancer Center, Houston, USA TrialPhase 3, VELIA ConferenceESMO 2019 26 November, 2019 22:26